In 2023, the re-imbursed pharmaceutical market for generics in Italy stood at a certain base value. The forecasted data indicates a steady but modest increase in this market from 2024 to 2028. The year-on-year variation expects an incremental rise from 9.8 in 2024 to 10 in 2028, resulting in a gradual but noticeable growth.

Key trends to watch for in the future include:

Market stabilization post-2026 with consistent growth readings.
Potential for increased government policies favoring the use of generics.
Technological advancements in pharmaceutical manufacturing could reduce costs and increase market adoption.
Possible shifts in healthcare budgets and reimbursement policies.